June 18, 2020 Corporate and Business News

• Wealth Managers Must Accelerate Change to Navigate Market Disruption

• Innovent Announces First Patient Dosed in A Phase 1b/2 Clinical Trial of IBI362, a Dual GLP-1 and Glucagon Receptor Agonist, in China

• Senseon (a Division of Accuride International) and Anixter International Announce Channel Partner Relationship to Create Comprehensive Security Solutions

• Back to Home

• Archive History